'5-in-1' Seed-Sized Surgical Robot Switches Tools in Under One Second

Why It Matters

The robot’s multi‑function capability and rapid tool switching could shrink surgical incisions, lower patient risk, and enable targeted therapies that are currently impossible with conventional instruments, reshaping the future of minimally invasive medicine.

Key Takeaways

• Robot measures 4.4 mm, performs five functions via magnetic control
• Tool switching occurs in under one second, a record speed
• Soft magnetic materials enable selective activation of individual robot parts
• Added rolling motion gives six degrees of freedom for precise navigation
• Biocompatibility tests show >99% human skin cell viability

Pulse Analysis

The race to shrink surgical tools into the millimetre scale has accelerated as clinicians seek truly minimally invasive procedures. Traditional endoscopic instruments still require incisions large enough to accommodate rigid shafts, limiting access to deep or tortuous anatomy. Magnetic microrobotics emerged as a promising alternative because external fields can steer devices without onboard power sources. However, most prototypes have been single‑function—either locomoting or delivering a payload—leaving a gap between laboratory concepts and the multifunctional tools surgeons need.

NTU Singapore’s new 4.4 mm “5‑in‑1” robot narrows that gap by integrating cutting, gripping, drug‑release, tissue sampling and localized heating into a single soft body. The breakthrough lies in a reprogrammable magnetic core that can be magnetized, demagnetized and remagnetized in under a second, activating only the intended segment while leaving the rest inert. This selective actuation, combined with a sixth degree of freedom—rolling—delivers unprecedented positional control inside soft, irregular environments such as the gastrointestinal tract or tumor sites.

Beyond the laboratory, the platform opens pathways to hybrid systems that pair magnetic navigation with real‑time imaging, biosensing, and AI‑driven path planning. If regulatory hurdles are cleared, hospitals could deploy fleets of disposable microrobots for targeted biopsies, hyperthermia cancer therapy, or localized drug delivery, potentially reducing operating room time and postoperative complications. Market analysts estimate the global medical microrobotics sector could exceed $2 billion by 2035, driven by demand for precision medicine and cost‑effective minimally invasive solutions.